Display options
Cite
Pérez-Armendariz EM, Luna J, Miranda C, et al. Luteinizing and human chorionic gonadotropin hormones increase intercellular communication and gap junctions in cultured mouse leydig cells. Endocrine. 1996;4(2):141-57doi: 10.1007/BF02782759.
Pérez-Armendariz, E. M., Luna, J., Miranda, C., Talavera, D., & Romano, M. C. (1996). Luteinizing and human chorionic gonadotropin hormones increase intercellular communication and gap junctions in cultured mouse leydig cells. Endocrine, 4(2), 141-57. https://doi.org/10.1007/BF02782759
Pérez-Armendariz, E M, et al. "Luteinizing and human chorionic gonadotropin hormones increase intercellular communication and gap junctions in cultured mouse leydig cells." Endocrine vol. 4,2 (1996): 141-57. doi: https://doi.org/10.1007/BF02782759
Pérez-Armendariz EM, Luna J, Miranda C, Talavera D, Romano MC. Luteinizing and human chorionic gonadotropin hormones increase intercellular communication and gap junctions in cultured mouse leydig cells. Endocrine. 1996 Apr;4(2):141-57. doi: 10.1007/BF02782759. PMID: 21153269.
Copy Download .nbib Format: NLM
Share it on

Endocrine. 1996 Apr;4(2):141-57. doi: 10.1007/BF02782759.

Luteinizing and human chorionic gonadotropin hormones increase intercellular communication and gap junctions in cultured mouse leydig cells.

Endocrine

E M Pérez-Armendariz, J Luna, C Miranda, D Talavera, M C Romano

Affiliations

  1. Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY.

PMID: 21153269 DOI: 10.1007/BF02782759

Abstract

The effect of luteinizing (LH) and human chorionic gonadotropin (hCG) hormones on gap junctions (Gjs) and intercellular communication (ic) was evaluated in Leydig (interstitial) cells from mouse testes. Cell cultures enriched in Leydig cells were studied under control conditions and when maintained in the presence of 100 ng/mL LH, 10 ng/mL hCG, or 1 mM dibutiryl-cAMP (db-cAMP), for 8, 24, and 36 h. To monitor the extent of ic, Lucifer yellow (LY) was injected through a patch pipet into one cell of-small cell aggregates (6-10), and its transfer was evaluated using fluorescent microscopy. The expression of GJs was monitored using immunofluorescent (IF) labeling of connexin 43 (Cx43) with a specific antibody. Testosterone secretion was determined by radioimmunoassay. At all culture times, testosterone levels in the medium were higher in treated than in control cell cultures. In cell cultures of 8 h, LY transferred to most of the neighboring cells (93%) and cell membrane appositions showed abundant Cx43; no difference was found between control and treated cells. In contrast, in control cell cultures of 24 and 36 h, LY transferred to a reduced fraction of neighboring cells (46 and 21%, respectively) and Cx43 labeling was markedly decreased. Addition of LH, hCG, or db-cAMP, to cell cultures for 24 and 36 h completely prevented the decrease in ic and Cx43 expression. Immunoblot studies, from total protein homogenates of cell cultures of 36 h, showed that relative levels of 40- and 43-kDa bands, characteristic of Cx43, were higher in treated than in control cells. These results demonstrate that the expression of Cx43 and ic in Leydig cells is modulated by LH and hCG, and suggest that their effect is mediated by the second messenger of these hormones, cAMP.

References

  1. J Lipid Mediat. 1993 Mar-Apr;6(1-3):509-13 - PubMed
  2. Biol Reprod. 1993 Dec;49(6):1190-201 - PubMed
  3. Fertil Steril. 1996 Jan;65(1):87-93 - PubMed
  4. Endocrinology. 1990 May;126(5):2493-8 - PubMed
  5. Endocr Res. 1986;12(4):447-67 - PubMed
  6. Mol Endocrinol. 1992 Aug;6(8):1323-31 - PubMed
  7. Cancer. 1989 May 15;63(10):1892-903 - PubMed
  8. Endocrinology. 1986 Apr;118(4):1660-8 - PubMed
  9. Endocrinology. 1992 Jun;130(6):3113-21 - PubMed
  10. Mol Endocrinol. 1987 May;1(5):348-54 - PubMed
  11. Biol Reprod. 1988 Nov;39(4):873-81 - PubMed
  12. Mol Cell Endocrinol. 1994 Apr;100(1-2):51-4 - PubMed
  13. J Clin Endocrinol Metab. 1994 Jul;79(1):106-12 - PubMed
  14. Endocrinology. 1993 Mar;132(3):1353-8 - PubMed
  15. Biol Reprod. 1987 Aug;37(1):211-23 - PubMed
  16. J Endocrinol. 1993 Aug;138(2):291-8 - PubMed
  17. Am J Obstet Gynecol. 1989 Apr;160(4):984-9 - PubMed
  18. J Reprod Fertil Suppl. 1991;43:65-75 - PubMed
  19. Endocrinology. 1993 May;132(5):2239-45 - PubMed
  20. Am J Obstet Gynecol. 1988 Feb;158(2):350-6 - PubMed
  21. Biol Reprod. 1986 Nov;35(4):863-72 - PubMed
  22. J Cell Biol. 1992 Apr;117(1):121-33 - PubMed
  23. Ann N Y Acad Sci. 1995 Dec 29;774:47-58 - PubMed
  24. Endocrinology. 1989 Oct;125(4):1959-66 - PubMed
  25. J Clin Endocrinol Metab. 1990 Apr;70(4):1041-5 - PubMed
  26. Mol Cell Endocrinol. 1989 Aug;65(1-2):1-11 - PubMed
  27. Endocrinology. 1987 Nov;121(5):1908-10 - PubMed
  28. Endocr Res. 1991;17(1-2):281-96 - PubMed
  29. Biochem J. 1986 Nov 1;239(3):505-11 - PubMed
  30. Biol Reprod. 1989 Apr;40(4):703-8 - PubMed
  31. J Clin Endocrinol Metab. 1981 May;52(5):994-1001 - PubMed
  32. Endocr Rev. 1985 Summer;6(3):371-99 - PubMed
  33. J Steroid Biochem. 1985 Nov;23(5B):771-8 - PubMed
  34. J Clin Endocrinol Metab. 1979 Jan;48(1):153-8 - PubMed
  35. J Soc Gynecol Investig. 1995 Jan-Feb;2(1):30-7 - PubMed
  36. J Endocrinol. 1996 Feb;148(2):213-21 - PubMed
  37. Endocrinology. 1993 May;132(5):1945-51 - PubMed
  38. JAMA. 1989 Oct 6;262(13):1826-33 - PubMed
  39. J Clin Endocrinol Metab. 1996 Jan;81(1):257-63 - PubMed
  40. Mol Cell Endocrinol. 1989 Aug;65(1-2):187-93 - PubMed

Publication Types